Anti-anginal and anti-ischaemic effects of the If current inhibitor ivabradine in patients with stable angina pectoris receiving standard doses of beta-blockers. A 4-month randomised, double-blind, multicenter trial
Published in 2008 by
Thomas Kahan 
